肺癌合并肺栓塞的原因分析与治疗进展(3)
[8]Agnelli G，George DJ，Kakkar AK，et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer[J].N Engl J Med，2012，366：601-609.
[9]Kahn SR，Lim W，Dunn AS，et al. Prevention of VTE in nonsurgical patients： Antithrombotic Therapy and Prevention of Thrombosis， 9th ed：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest，2012，141(2 Suppl)：e195S-226S.
[10]Delate T，Witt DM，Ritzwoller D，et al.Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer[J].Oncologist，2012，17：419-427.
[11]Haas SK，Freund M，Heigener D，et al. Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer[J].Clin Appl Thromb Hemost，2012，18：159-165.
[12]Patel A，Anraku M，Darling GE，et al. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies[J].J Thorac Cardiovasc Surg，2009，138：843-848.编辑/翟辰万, 百拇医药(高超)
[9]Kahn SR，Lim W，Dunn AS，et al. Prevention of VTE in nonsurgical patients： Antithrombotic Therapy and Prevention of Thrombosis， 9th ed：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest，2012，141(2 Suppl)：e195S-226S.
[10]Delate T，Witt DM，Ritzwoller D，et al.Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer[J].Oncologist，2012，17：419-427.
[11]Haas SK，Freund M，Heigener D，et al. Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer[J].Clin Appl Thromb Hemost，2012，18：159-165.
[12]Patel A，Anraku M，Darling GE，et al. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies[J].J Thorac Cardiovasc Surg，2009，138：843-848.编辑/翟辰万, 百拇医药(高超)